A.R.T. Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-13,128
Closed -$72K 724
2019
Q4
$72K Buy
+13,128
New +$73.9K ﹤0.01% 1234
2018
Q1
Sell
-13,930
Closed -$160K 1700
2017
Q4
$160K Sell
13,930
-32,167
-70% -$479K 0.01% 1199
2017
Q3
$876K Sell
46,097
-27,000
-37% -$556K 0.04% 596
2017
Q2
$1.76M Buy
+73,097
New +$1.6M 0.09% 307
2017
Q1
Sell
-33,196
Closed -$799K 1642
2016
Q4
$799K Buy
+33,196
New +$924K 0.05% 556

Other funds holding PGEN

A.R.T. Advisors's PGEN Position: Q1 2020 in Review

A.R.T. Advisors sold out of Precigen (PGEN) in Q1 2020, closing a stake of 13,128 shares — an estimated $72K sold.

A.R.T. Advisors first reported a position in PGEN in Q4 2016 and held it in 5 quarters. The position peaked at $1.76M in Q2 2017. 151 funds tracked by Wall St. Rank hold PGEN as of Q1 2020.

  • A.R.T. Advisors reported no remaining Precigen position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 13,128 Precigen shares in Q1 2020, an estimated $72K.
  • A.R.T. Advisors first reported a position in Precigen in Q4 2016 and held it in 5 quarters.
  • A.R.T. Advisors's Precigen position peaked at $1.76M in Q2 2017.
  • 151 funds tracked by Wall St. Rank held Precigen as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.